Bioequivalence clinical trial of dapagliflozin 10 mg tablets, after a single oral dose administration to healthy volunteers under fasting conditions.
UECHUP-DAP/24-4
Phase 1 other active
Quick answer
Bioequivalence clinical trial of dapagliflozin 10 mg tablets, after a single oral dose administration to healthy volunteers under fasting conditions. for Diabetes is a Phase 1 program (other) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Laboratorios Tillomed Spain S.L.U
- Indication
- Diabetes
- Phase
- Phase 1
- Modality
- other
- Status
- active